|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/7125 | (2006.01) |
| C07K 14/56 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3240801 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15876030.6 |
| Date of filing the European patent application | 2015-12-22 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-20 |
| (46) | Date of publication of the claims translation | 2021-02-25 |
| (86) | Number | PCT/US2015/067269 |
| Date | 2015-12-22 |
| (87) | Number | WO 2016/109310 |
| Date | 2016-07-07 |
| (30) | Number | Date | Country code |
| 201462098568 P | 2014-12-31 | US | |
| 201562106526 P | 2015-01-22 | US | |
| 201562118165 P | 2015-02-19 | US |
| (72) |
KRIEG, Arthur, M., US
|
| (73) |
Checkmate Pharmaceuticals, Inc.,
1 Broadway, 14th Floor, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuota navikų imunoterapija |
| COMBINATION TUMOR IMMUNOTHERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-11-19 | 11 | 289.00 EUR |
| 2026-12-22 |